ARS Pharmaceuticals Statistics
Total Valuation
SPRY has a market cap or net worth of $991.23 million. The enterprise value is $824.72 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRY has 98.83 million shares outstanding. The number of shares has increased by 1.51% in one year.
| Current Share Class | 98.83M |
| Shares Outstanding | 98.83M |
| Shares Change (YoY) | +1.51% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 9.99% |
| Owned by Institutions (%) | 58.05% |
| Float | 52.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.72 |
| Forward PS | 7.23 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 5.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.17, with a Debt / Equity ratio of 0.38.
| Current Ratio | 6.17 |
| Quick Ratio | 5.84 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.56% and return on invested capital (ROIC) is -15.41%.
| Return on Equity (ROE) | -23.56% |
| Return on Assets (ROA) | -13.85% |
| Return on Invested Capital (ROIC) | -15.41% |
| Return on Capital Employed (ROCE) | -22.15% |
| Revenue Per Employee | $702,119 |
| Profits Per Employee | -$300,106 |
| Employee Count | 160 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SPRY has paid $288,000 in taxes.
| Income Tax | 288,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.42% in the last 52 weeks. The beta is 0.92, so SPRY's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -16.42% |
| 50-Day Moving Average | 15.37 |
| 200-Day Moving Average | 13.72 |
| Relative Strength Index (RSI) | 25.69 |
| Average Volume (20 Days) | 3,115,527 |
Short Selling Information
The latest short interest is 21.04 million, so 21.29% of the outstanding shares have been sold short.
| Short Interest | 21.04M |
| Short Previous Month | 17.77M |
| Short % of Shares Out | 21.29% |
| Short % of Float | 40.39% |
| Short Ratio (days to cover) | 10.08 |
Income Statement
In the last 12 months, SPRY had revenue of $112.34 million and -$48.02 million in losses. Loss per share was -$0.49.
| Revenue | 112.34M |
| Gross Profit | 90.85M |
| Operating Income | -59.34M |
| Pretax Income | -44.84M |
| Net Income | -48.02M |
| EBITDA | -58.73M |
| EBIT | -59.34M |
| Loss Per Share | -$0.49 |
Full Income StatementBalance Sheet
The company has $240.13 million in cash and $73.62 million in debt, giving a net cash position of $166.51 million or $1.68 per share.
| Cash & Cash Equivalents | 240.13M |
| Total Debt | 73.62M |
| Net Cash | 166.51M |
| Net Cash Per Share | $1.68 |
| Equity (Book Value) | 192.32M |
| Book Value Per Share | 1.95 |
| Working Capital | 235.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$52.80 million and capital expenditures -$584,000, giving a free cash flow of -$53.38 million.
| Operating Cash Flow | -52.80M |
| Capital Expenditures | -584,000 |
| Free Cash Flow | -53.38M |
| FCF Per Share | -$0.54 |
Full Cash Flow StatementMargins
Gross margin is 80.87%, with operating and profit margins of -52.82% and -42.74%.
| Gross Margin | 80.87% |
| Operating Margin | -52.82% |
| Pretax Margin | -42.49% |
| Profit Margin | -42.74% |
| EBITDA Margin | -52.28% |
| EBIT Margin | -52.82% |
| FCF Margin | n/a |
Dividends & Yields
SPRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.51% |
| Shareholder Yield | -1.51% |
| Earnings Yield | -4.84% |
| FCF Yield | -5.39% |
Analyst Forecast
The average price target for SPRY is $31.00, which is 209.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.00 |
| Price Target Difference | 209.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 53.95% |
| EPS Growth Forecast (5Y) | 63.27% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRY has an Altman Z-Score of 6.05 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.05 |
| Piotroski F-Score | 2 |
